Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Recommendation Against Chemotherapy Sensitivity, Resistance Assays

04.08.2004


A new technology assessment from the American Society of Clinical Oncology (ASCO) states that the use of chemotherapy sensitivity and resistance assays (CSRAs) to select chemotherapeutic agents for cancer patients should not be undertaken outside of the clinical trial setting.

CSRAs are an in-vitro laboratory analysis used to help determine whether a specific chemotherapy regimen might inhibit tumor growth in a specific patient. This type of analysis contrasts with so-called empiric therapy, where chemotherapy treatment is chosen based on clinical literature describing outcomes achieved through a specific clinical trial.

ASCO underscores that the idea of tailoring treatment to individual patients – using effective agents while sparing unnecessary ones – has obvious and great appeal, but ultimately found that limitations in the literature about CSRAs, including small sample sizes, a lack of prospective studies, low yield of assays, and newer chemotherapy drugs that continue to be developed, cast doubt as to their actual effectiveness of CSRAs in determining a course of treatment.



Furthermore, for technically challenging assays that require colony formation, such as the human tumor cloning assay, and for surgical procedures including the sub-renal capsule assay, the success rate of the CSRA procedure is modest. In addition, preparation of the assay may involve complex laboratory work, limiting a broad application of the technology to routine clinical practice.

“I was glad to see that our technology assessment felt that clinical trial work on the use of chemotherapy and resistance assays should continue,” said Daniel Von Hoff, MD, FACP, Director of Arizona Health Science Center Cancer Therapeutics Program and Professor in the Department of Medicine, Molecular and Cellular Biology and Pathology, at The University of Arizona College of Medicine. “Obviously there is a great need for these assays particularly with the more targeted therapeutic agents that are being developed.”

ASCO recommends that oncologists instead make chemotherapy treatment recommendations based on published reports of clinical trials and a patient’s health status and treatment preferences.

ASCO does recommend that research into the potential for using CSRAs as a tool for determining appropriate treatment should continue. “As laboratory procedures become more advanced, better assays will be developed,” said Deborah Schrag, MD, a medical oncologist and member of the Health Outcomes Research Group at Memorial Sloan Kettering Cancer Center in New York City. “In addition, as more chemotherapy drugs become available, and treatment choices for oncologists become more complex, the rationale for developing CSRAs becomes more persuasive.”

ASCO defines a technology assessment as a process for determining whether a procedure is appropriate for broad-based use in clinical practices. Of an initial review of more than 1,100 articles, the ASCO Working Group found 12 articles that were relevant to include in a technology assessment of CSRAs and analyzed their results.

ASCO also released a new evidence-based technology assessment, Chemotherapy Sensitivity and Resistance Assays, the patient version of the clinical practice recommendations.

“American Society of Clinical Oncology Technology Assessment: Chemotherapy Sensitivity and Resistance Assays.” D. Schrag, MD, et al, Memorial Sloan-Kettering Cancer Center, New York, NY.

The guideline has been published ahead of print August 2, 2004, in the Journal of Clinical Oncology (JCO), the semi-monthly peer-reviewed journal of the American Society of Clinical Oncology (ASCO), the world’s leading professional society representing physicians who treat people with cancer.

| newswise
Further information:
http://www.asco.org
http://www.plwc.org
http://www.jco.org

More articles from Health and Medicine:

nachricht TSRI researchers develop new method to 'fingerprint' HIV
29.03.2017 | Scripps Research Institute

nachricht Periodic ventilation keeps more pollen out than tilted-open windows
29.03.2017 | Technische Universität München

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Challenging European Research Project to Develop New Tiny Microscopes

The Institute of Semiconductor Technology and the Institute of Physical and Theoretical Chemistry, both members of the Laboratory for Emerging Nanometrology (LENA), at Technische Universität Braunschweig are partners in a new European research project entitled ChipScope, which aims to develop a completely new and extremely small optical microscope capable of observing the interior of living cells in real time. A consortium of 7 partners from 5 countries will tackle this issue with very ambitious objectives during a four-year research program.

To demonstrate the usefulness of this new scientific tool, at the end of the project the developed chip-sized microscope will be used to observe in real-time...

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Researchers shoot for success with simulations of laser pulse-material interactions

29.03.2017 | Materials Sciences

Igniting a solar flare in the corona with lower-atmosphere kindling

29.03.2017 | Physics and Astronomy

As sea level rises, much of Honolulu and Waikiki vulnerable to groundwater inundation

29.03.2017 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>